The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Involvement of Human Micro-RNA in Growth and Response to Chemotherapy in Human Cholangiocarcinoma Cell Lines
Open accessAbstract
Background & aims Micro-RNA (miRNA) are endogenous regulatory RNA molecules that modulate gene expression. Alterations in miRNA expression can contribute to tumor growth by modulating the functional expression of critical genes involved in tumor cell proliferation or survival. Our aims were to identify specific miRNA involved in the regulation of cholangiocarcinoma growth and response to chemotherapy. Methods miRNA expression in malignant and nonmalignant human cholangiocytes was assessed using a microarray. Expression of selected miRNA and their precursors was evaluated by Northern blots and real-time polymerase chain reaction, respectively. The effect of selected miRNA on cell growth and response to chemotherapy was assessed using miRNA-specific antisense oligonucleotides to decrease miRNA expression or with precursor miRNA to increase cellular expression. Results miRNA expression was markedly different in malignant cholangiocytes, with decreased expression of many miRNA compared with nonmalignant cells. A cluster of miRNA, including miR-320, miR-200b, miR-21, miR-23a, miR-141, miR-27a, and miR-34a, were expressed in all cell lines. MiR-21, miR-141, and miR-200b were highly over-expressed in malignant cholangiocytes. Inhibition of miR-21 and miR-200b increased sensitivity to gemcitabine, whereas inhibition of miR-141 decreased cell growth. Treatment of tumor cell xenografts with systemic gemcitabine altered the expression of a significant number of miRNA. miR-21 modulates gemcitabine-induced apoptosis by phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-dependent activation of PI 3-kinase signaling. Potential target genes that were modulated by selected miRNA were identified. Conclusions Alterations in miRNA expression contribute to tumor growth and response to chemotherapy. Aberrantly expressed miRNA or their targets will provide mechanistic insight and therapeutic targets for cholangiocarcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Three miR-21 targets have, thus far, been described: phosphatase and tensin homologue (PTEN), programmed cell death 4 (PDCD4) and Tropomyosin 1 (TPM1; refs.10,[14][15][16].”
From MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells (2008) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
TM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando, E., Mu, D., Goodson, S. G., Powers, S., Cordon‐Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,642
An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans
Lau, N. C., Lim, L. P., Weinstein, E. G., & Bartel, D. P. (2001) · Science · doi:10.1126/science.1065062 · Cited by 3,345
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,782
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M., & Sarnow, P. (2005) · Science · doi:10.1126/science.1113329 · Cited by 2,580
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Self-citation
Flagged first, then by citations
2 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 983
miR-373 Negatively Regulates Methyl-CpG-Binding Domain Protein 2 (MBD2) in Hilar Cholangiocarcinoma
Chen, Y., Luo, J., Tian, R., Sun, H.-W., & Zou, S. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1481-1 · Cited by 61
Saito, H., Noji, T., Okamura, K., Tsuchikawa, T., Shichinohe, T., & Hirano, S. (2015) · Surgery · doi:10.1016/j.surg.2015.10.027 · Cited by 60
Pratheeshkumar, P., Son, Y., Divya, S. P., Turcios, L. M., Roy, R. V., Hitron, J. A., Wang, L., Kim, D., Dai, J., Asha, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9967 · Cited by 61
Zhou, B., Wang, J., Zheng, G., & Qiu, Z. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.10.005 · Cited by 60
Cholesteatoma Growth and Proliferation
Friedland, D. R., Eernisse, R., Erbe, C. B., Gupta, N., & Cioffi, J. A. (2009) · Otology & Neurotology · doi:10.1097/mao.0b013e3181b4e91f · Cited by 59
He, Q., Cai, L., Shuai, L., Li, D., Wang, C., Liu, Y., Li, X., Li, Z., & Wang, S. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.21859 · Cited by 59
The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma
Park, Y.-A., Lee, J., Choi, J., Jeon, H.-K., Cho, Y., Choi, C.-H., Kim, T., Lee, N. W., Kim, B., & Bae, D. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.09.026 · Cited by 59
Cui, X.-S., Xu, Y., Shen, X., Zhang, L.-Q., Zhang, J., & Kim, N. (2011) · Cellular Reprogramming · doi:10.1089/cell.2010.0060 · Cited by 59
Potential Role of microRNA-21 in the Diagnosis of Gastric Cancer: A Meta-Analysis
Zeng, Z., Wang, J., Zhao, L., Hu, P., Zhang, H., Tang, X., He, D., Tang, S., & Zeng, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073278 · Cited by 58
Current and novel therapeutic opportunities for systemic therapy in biliary cancer
Marı́n, J. J. G., Prete, M. G., Lamarca, Á., Tavolari, S., Landa-Magdalena, A., Brandi, G., Segatto, O., Vogel, A., Macı́as, R. I. R., Rodrigues, P. M., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0987-3 · Cited by 58
Shielding the messenger (RNA): microRNA-based anticancer therapies
Sotillo, E., & Thomas‐Tikhonenko, A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.04.006 · Cited by 59
miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA)
Zheng, B. J., Jeong, S., Zhu, Y., Chen, L., & Xia, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.19044 · Cited by 57
Analysis of the circular RNA transcriptome in endometrial cancer
Chen, B. J., Byrne, F. L., Takenaka, K., Modesitt, S. C., Olzomer, E. M., Mills, J. D., Farrell, R., Hoehn, K. L., & Janitz, M. (2017) · Oncotarget · doi:10.18632/oncotarget.23534 · Cited by 57
Babaei, K., Shams, S., Keymoradzadeh, A., Vahidi, S., Hamami, P., Khaksar, R., Norollahi, S. E., & Samadani, A. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117077 · Cited by 59
Nguyen, H. T., Kacimi, S. E. O., Nguyen, T. L., Suman, K. H., Lemus-Martin, R., Saleem, H., & Do, D. N. (2021) · Biology · doi:10.3390/biology10050417 · Cited by 57
Li, Y., Zhu, X., Gu, J., Hu, H., Dong, D., Yao, J., Lin, C., & Jia, F. (2010) · Hematology · doi:10.1179/102453310x12647083620840 · Cited by 57
Sayed, D. H., & Abdellatif, M. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12634 · Cited by 59
Xiong, X., Ren, H., Li, M., Mei, J., Wen, J., & Zheng, C.-L. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9406-7 · Cited by 57
Tao, L., Wu, Y., & Zhang, S. (2019) · Neoplasma · doi:10.4149/neo_2018_181207n930 · Cited by 58
MicroRNA-induced drug resistance in gastric cancer
Dehghanzadeh, R., Jadidi‐Niaragh, F., Gharibi, T., & Yousefi, M. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.08.009 · Cited by 57
MiR-21/RASA1 axis affects malignancy of colon cancer cellsviaRAS pathways
Gong, B. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i5.1488 · Cited by 59
Towards the definition of prostate cancer-related microRNAs: where are we now?
Gandellini, P., Folini, M., & Zaffaroni, N. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.07.004 · Cited by 56
Wen, F., An, C., Wu, X., Yang, Y., Xu, J., Liu, Y., Wang, C., Nie, L., Fang, H., & Yang, Z. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.11.008 · Cited by 57
Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review
Tshering, G., Dorji, P. W., Chai่jaroenkul, W., & Na‐Bangchang, K. (2018) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.17-0879 · Cited by 56
Noncoding RNA in Cholangiocarcinoma
Salati, M., & Braconi, C. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1676097 · Cited by 56
The role of microRNAs in primary liver cancer
Varnholt, H. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31864-2 · Cited by 56
Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer
Ochiya, T. (2012) · Frontiers in bioscience · doi:10.2741/4096 · Cited by 55
MicroRNA-21 is a novel promising target in cancer radiation therapy
Liu, J., Zhu, H., Yang, X., Ge, Y., Zhang, C., Qin, Q., Lü, J., Zhan, L., Cheng, H., & Sun, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-1623-8 · Cited by 56
miRNA genetic alterations in human cancers
Giannakakis, A., Coukos, G., Hatzigeorgiou, A. G., Sandaltzopoulos, R., & Zhang, L. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.9.1375 · Cited by 54
Marsh, R., Alonzo, M. J., Bajaj, S., Baker, M. S., Elton, E., Farrell, T. A., Gore, R. M., Hall, C. R., Nowak, J. A., Roy, H. K., et al. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23028 · Cited by 54
Non-coding RNAs—Novel targets in neurotoxicity
Tal, T. L., & Tanguay, R. L. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.02.013 · Cited by 55
LI, T., Yin, J., Yuan, L., Wang, S., Yang, L., Du, X., & Lu, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3032 · Cited by 53
Cava, C., Bertoli, G. R., & Castiglioni, I. (2015) · BMC Systems Biology · doi:10.1186/s12918-015-0211-x · Cited by 57
Komatsu, S., Ichikawa, D., Kawaguchi, T., Miyamae, M., Okajima, W., Ohashi, T., Imamura, T., Kiuchi, J., Konishi, H., Shiozaki, A., et al. (2016) · Europe PMC (PubMed Central) · Cited by 52
Li, L., Gan, H., Zhang, H., Tang, W., Sun, Y., Tang, X., Kong, D., Zhou, J., WANG, Y., & Zhu, Y. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2312 · Cited by 52
Regulation of gene expression by microRNA in HCV infection and HCV–mediated hepatocellular carcinoma
Gupta, P., Cairns, M. J., & Saksena, N. K. (2014) · Virology Journal · doi:10.1186/1743-422x-11-64 · Cited by 51
Cholangiocarcinoma: principles and current trends
Zografos, G. N., Farfaras, A., Zagouri, F., Chrysikos, D., & Karaliotas, K. (2011) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(11)60001-5 · Cited by 51
Yanokura, M., Banno, K., Kobayashi, Y., Kisu, I., Ueki, A., Ono, A., Masuda, K., Nomura, H., Hirasawa, A., Susumu, N., et al. (2010) · Oncology Letters · doi:10.3892/ol.2010.173 · Cited by 51
Shen, Y., Jiang, Y., Greenlee, A. R., Zhou, L., & Liu, L. (2009) · Biomedical and Environmental Sciences · doi:10.1016/s0895-3988(09)60016-7 · Cited by 52
microRNAs: a role in drug resistance in parasitic nematodes?
Devaney, E., Winter, A. D., & Britton, C. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2010.05.003 · Cited by 53
He, P., Zhang, Z., Huang, G., Wang, H., Xu, D., Liao, W., & Kang, Y. (2016) · PubMed Central · Cited by 51
Puik, J. R., Meijer, L. L., Large, T. Y. S. L., Prado, M. M., Frampton, A. E., Geert Kazemier, M., & Giovannetti, E. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0010 · Cited by 51
Bogert, P. S. T., & LaRusso, N. F. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3280b079fb · Cited by 51
MicroRNA in human cancer and chronic inflammatory diseases
Kanwar, R. K. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s121 · Cited by 52
Noncoding RNAs in DNA Repair and Genome Integrity
Wan, G., Liu, Y., Han, C., Zhang, X., & Lu, X. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5514 · Cited by 50
Mi RNA s in primary cutaneous lymphomas
Yu, X., Li, Z., & Liu, J. (2015) · Cell Proliferation · doi:10.1111/cpr.12179 · Cited by 50
The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer
Shen, Y., Pan, X., & Zhao, H. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.076 · Cited by 49
microRNA-34a promotes DNA damage and mitotic catastrophe
Kofman, A. V., Kim, J., Park, S., Dupart, E., Letson, C. S., Bao, Y., Ding, K., Chen, Q., Schiff, D., Larner, J. M., et al. (2013) · Cell Cycle · doi:10.4161/cc.26459 · Cited by 50
Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity
Schmuck, R. B., de Carvalho‐Fischer, C. V., Neumann, C., Pratschke, J., & Bahra, M. (2015) · Cancer Medicine · doi:10.1002/cam4.566 · Cited by 50
MicroRNAs and extracellular vesicles in cholangiopathies
Olaizola, P., Lee, P. Y., Arbelaiz, A., Lapitz, A., Perugorria, M. J., Bujanda, L., & Bañales, J. M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.026 · Cited by 52
Role of phytochemicals in the modulation of miRNA expression in cancer
Debnath, T., Nath, N. C. D., Kim, E., & Lee, K. (2017) · Food & Function · doi:10.1039/c7fo00739f · Cited by 53
Zhan, T., Huang, X., Xia, T., Chen, X., Ding, Y., Luo, H., & Zhang, Y. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.12.002 · Cited by 50
Advances in MicroRNAs: Implications for Gene Therapists
Marquez, R. T., & McCaffrey, A. P. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.147 · Cited by 50
Areca Nut Induces miR-23a and Inhibits Repair of DNA Double-Strand Breaks by Targeting FANCG
Tsai, Y., Lin, C., Chiang, S., Lee, C., Lee, K., & Ko, Y. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr182 · Cited by 50
Pathogenic mechanisms of deregulated microRNA expression in thyroid carcinomas of follicular origin
Braun, J., & Hüttelmaier, S. (2011) · Thyroid Research · doi:10.1186/1756-6614-4-s1-s1 · Cited by 50
Iwaki, J., Kikuchi, K., Mizuguchi, Y., Kawahigashi, Y., Yoshida, H., Uchida, E., & Takizawa, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069496 · Cited by 49
Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers
Letelier, P. J., Riquelme, I., Hernández, A., Guzmán, N. H., Farías, J. G., & Roa, J. C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050791 · Cited by 49
Samukawa, E., Fujihara, S., Oura, K., Iwama, H., Yamana, Y., Tadokoro, T., Chiyo, T., Kobayashi, K., Morishita, A., Nakahara, M., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4177 · Cited by 49
Unique MicroRNA Signature and Clinical Outcome of Cancers
Yu, S., Chen, H., Yang, P., & Chen, J. J. W. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0555 · Cited by 48
Yang, R., Chen, Y., Tang, C., Li, H., Wang, B., Yan, Q., Hu, J., & Zou, S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-917 · Cited by 48
DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity
van Jaarsveld, M. T. M., Wouters, M. D., Boersma, A. W. M., Smid, M., van IJcken, W. F. J., Mathijssen, R. H. J., Hoeijmakers, J. H. J., Martens, J. W. M., Laere, S. V., Wiemer, E. A. C., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.12.011 · Cited by 47
Sadakari, Y., Ohtsuka, T., Ohuchida, K., Tsutsumi, K., Takahata, S., Nakamura, M., Mizumoto, K., & Tanaka, M. (2015) · PubMed · doi:10.6092/1590-8577/3402 · Cited by 48
Huang, S., Li, X.-Q., Chen, X., Che, S.-M., Chen, W., & Zhang, X.-Z. (2012) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2012.01389.x · Cited by 48
Karmon, A. E., Cardozo, E. R., Rueda, B. R., & Styer, A. K. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu017 · Cited by 48
Regulatory roles of microRNA-21 in fibrosis through interaction with diverse pathways (Review)
Liu, R., Ning, B., MA, X.-E., Gong, W.-M., & Jia, T. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4834 · Cited by 51
Zhang, P., Kong, F., Deng, X., Yu, Y., Hou, C., Liang, T., & Zhu, L. (2017) · Oncology Letters · doi:10.3892/ol.2017.5852 · Cited by 48
Epigenome dysregulation in cholangiocarcinoma
O’Rourke, C. J., Muñoz-Garrido, P., Aguayo, E. L., & Andersen, J. B. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.014 · Cited by 48
miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
Liu, K., Liu, S., Zhang, W., Ji, B., Wang, Y., & Liu, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2577 · Cited by 48
RetractedNygaard, S., Skanderup, A. J., Lindow, M., Eriksen, J., Balslev, E., Flyger, H., Tolstrup, N., Møller, S., Krogh, A., & Litman, T. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-35 · Cited by 48
A precursor microRNA in a cancer cell nucleus
Melo, S. A., & Esteller, M. (2011) · Cell Cycle · doi:10.4161/cc.10.6.15119 · Cited by 47
Liu, L., Jiang, Y., Zhang, H., Greenlee, A. R., Yu, R., & Yang, Q. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.02.016 · Cited by 47
Clinical Potential of MicroRNAs in Pancreatic Ductal Adenocarcinoma
Steele, C. W., Oien, K. A., McKay, C. J., & Jamieson, N. B. (2011) · Pancreas · doi:10.1097/mpa.0b013e3182218ffb · Cited by 48
MicroRNA-21 induces cell proliferation and invasion in esophageal squamous cell carcinoma
Ishiguro (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000089 · Cited by 47
MiR-21 is Continually Elevated Long-Term in the Brain after Exposure to Ionizing Radiation
Shi, Y., Zhang, X., Tang, X., Wang, P., Wang, H., & Wang, Y. (2011) · Radiation Research · doi:10.1667/rr2764.1 · Cited by 47
Li, Y., Liu, J., Yuan, C., Cui, B., Zou, X., & Qiao, Y. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800518 · Cited by 47
Arisawa, T., Tahara, T., Shibata, T., Nagasaka, M., Nakamura, M., Kamiya, Y., Fujita, H., Hasegawa, S., Takagi, T., Wang, F.-Y., et al. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9648-5 · Cited by 47
MicroRNAs in Human Embryonic and Cancer Stem Cells
Navarro, A., & Monzó, M. (2010) · Yonsei Medical Journal · doi:10.3349/ymj.2010.51.5.622 · Cited by 47
Shen, X., Han, Y., Zhang, D., Cui, X., & Kim, N. (2009) · Molecular Reproduction and Development · doi:10.1002/mrd.21048 · Cited by 45
Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways
Kongpetch, S., Jusakul, A., Ong, C. K., Lim, W. K., Rozen, S., Tan, P. B. O., & Teh, B. T. (2015) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2015.02.002 · Cited by 46
A Differential MicroRNA Profile Distinguishes Cholangiocarcinoma from Pancreatic Adenocarcinoma
Collins, A., Wojcik, S. E., Liu, J., Frankel, W. L., Alder, H., Yu, L., Schmittgen, T. D., Croce, C. M., & Bloomston, M. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3240-y · Cited by 46
Self-citationmiR-21: A Key Small Molecule with Great Effects in Combination Cancer Therapy
Arghiani, N., & Matin, M. M. (2021) · Nucleic Acid Therapeutics · doi:10.1089/nat.2020.0914 · Cited by 47
Junker, F., Chabloz, A., Koch, U., & Radtke, F. (2015) · Blood · doi:10.1182/blood-2014-12-618892 · Cited by 45
microRNAs in liver disease: From diagnostics to therapeutics
Takahashi, K., Yan, I. K., Wen, H.-J., & Patel, T. C. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.01.025 · Cited by 46
Self-citationGene expression and epigenetic changes by furan in rat liver
Chen, T., Williams, T., Mally, A., Hamberger, C., Mirbahai, L., Hickling, K., & Chipman, J. K. (2011) · Toxicology · doi:10.1016/j.tox.2011.10.020 · Cited by 45
Involvement of MicroRNAs in Breast Cancer
Adams, B. D., Reed, I. K. G., & White, B. A. (2008) · Seminars in Reproductive Medicine · doi:10.1055/s-0028-1096132 · Cited by 44
Oncomirs: From Tumor Biology to Molecularly Targeted Anticancer Strategies
D, S. M. M., Pasquali, S., & Pilati, P. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787001802 · Cited by 45
Interplay Between Metabolism and Oncogenic Process: Role of microRNAs
Arora, A., Singh, S. P., Bhatt, A. N., Pandey, S., Sandhir, R., & Dwarakanath, B. S. R. (2015) · Translational Oncogenomics · doi:10.4137/tog.s29652 · Cited by 43
The Multifaceted Role of miR-21 in Pancreatic Cancers
Chen, C., Demirkhanyan, L. H., & Gondi, C. S. (2024) · Cells · doi:10.3390/cells13110948 · Cited by 48
Petrelli, A., Carollo, R., Cargnelutti, M., Iovino, F., Callari, M., Cimino, D., Todaro, M., Mangiapane, L. R., Giammona, A., Cordova, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2962 · Cited by 44
Ghodgaonkar, M. M., Shah, R. G., Kandan-Kulangara, F., Affar, E.-B., Qi, H. H., Wiemer, E. A. C., & Shah, G. M. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.15 · Cited by 44
Circulating microRNAs: Novel biomarkers for esophageal cancer
Zhou, S. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i19.2348 · Cited by 47
Biliary tract carcinomas: From chemotherapy to targeted therapy
Marino, D., Leone, F., Cavalloni, G., Cagnazzo, C., & Aglietta, M. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.06.006 · Cited by 44
Epigenetic alterations associated with cholangiocarcinoma (Review)
Isomoto (2009) · Oncology Reports · doi:10.3892/or_00000428 · Cited by 44
Nedaeinia, R., Sharifi, M., Avan, A., Kazemi, M., Nabinejad, A., Ferns, G. A., Ghayour-Mobarhan, M., & Salehi, R. (2017) · Tumor Biology · doi:10.1177/1010428317692261 · Cited by 47
Circular RNAs in cholangiocarcinoma
Liao, W., Feng, Q., Liu, H., Du, J., Chen, X., & Zeng, Y. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215980 · Cited by 44
Chen, Y., Zhang, L., & Hao, Q. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-86 · Cited by 43
Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinoma
Wei, M., Lü, L., Lin, P., Chen, Z., Quan, Z., & Tang, Z. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.038 · Cited by 44
Yu, T., Lu, X.-J., Li, J., Shan, T., Huang, C., Ouyang, H., Yang, H., Xu, J., Zhong, W., Xia, Z., et al. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2435-5 · Cited by 43
RetractedDillhoff, M. E., Wojcik, S. E., & Bloomston, M. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.02.046 · Cited by 43
Song, W., Wang, L., Huang, W., Cai, X., Cui, J., & Wang, L. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.12.7529 · Cited by 43
Metadata
- Authors
- Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T.
- Affiliations
- Texas A&M University System (US)
- Johns Hopkins University (US)
- The Ohio State University (US)
- Corresponding author
- Patel, Tushar
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 130
- Issue
- 7
- Pages
- 2113-2129
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1990645475
- Cited by
- 984
- References
- 44
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 13 · 2023: 24 · 2022: 26 · 2021: 27 · 2020: 22 · 2019: 28 · 2018: 27 · 2017: 49 · 2016: 60 · 2015: 64 · 2014: 86 · 2013: 76 · 2012: 65
- FWCI
- 27.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- OakTrust (Texas A&M University Libraries) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-069370, R01DK069370)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- microRNA, cholangiocarcinoma, miR-21, miR-200b, miR-141, gemcitabine, chemotherapy response, tumor cell proliferation, PTEN, PI3K signaling, apoptosis, miRNA expression profiling, cholangiocytes, xenografts, therapeutic target
- MeSH terms
- Gemcitabine, Animals, Deoxycytidine, Humans, Male, Mice, Nude, Probability, Sampling Studies, Sensitivity and Specificity, Transfection, Transplantation, Heterologous, Blotting, Northern, Blotting, Western, Gene Expression Regulation, Neoplastic, Apoptosis, Cholangiocarcinoma, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, MicroRNAs, Cell Line, Tumor, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
